MD Anderson trial uses psilocybin-assisted therapy to help head and neck cancer patients cope with trauma and improve recovery.
Moran Amit, MD, PhD
Advertisement
Moran Amit, MD, PhD, is a Surgeon-Scientist in the Department of Head and Neck Surgery and the Department of Genomic Medicine at MD Anderson Cancer Center, with faculty appointments in the UTHealth Graduate School of Biomedical Sciences
Articles by Moran Amit, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
When Consensus Outpaces Capacity in Second-Line Melanoma
2
ASCO 2026 Breast Cancer Trials Affirm De-Escalation, Earlier Switching
3
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer
4
Do Clinical Trial Results Hold Up in the Real World? A New Study on ALK+ Lung Cancer Says Yes—Mostly
5